Safety Lead
CurrentPrimary pharmacovigilance (PV) (safety) representative and contact for Sponsors, investigational sites, and Sarah Cannon Development Innovations (DI) project teams. Reviews safety sections of clinical study protocols, and is responsible for ensuring the appropriate safety reporting process is in place, and ensures compliance with global PV regulations, guidelines (e.g. ICH) and company policies. Appropriately escalating safety related issues Accountable for delivery of a detailed Safety Monitoring Plan (SMP) for clinical studies, describing the end-to-end process for safety reporting, compliant with study protocol, Sponsor requirements, and applicable PV regulations. Reviews safety case reports to ensure Argus safety database entry is complete and accurate, prepares a comprehensive and medically coherent clinical narrative for safety cases, determines the expectedness of an event for regulatory reporting purposes, codes medical terminology using standardized dictionary (e.g. MedDRA), and identifies queries required for accurate assessment. Prepares expedited individual safety reports, submits to relevant competent authorities (e.g. EMEA, MHRA), and is responsible for ensuring further submissions via sponsor or regulatory function e.g. FDA and site EC/IRB. Leads regular cumulative safety reviews for studies, defines and ensures delivery of supporting safety outputs (TLFs), reviews safety data and drafts a summary, works with Safety Physician and Medical Monitor to finalize meeting content, presents data at cross-functional safety review meeting Conduct all activities according to the company SOPs, GCPs, ICH regulations and guidelines.